Matrix metalloproteases-responsive nanomaterials for tumor targeting diagnosis and treatment

References

• Abouelmagd SA, Hyun H, Yeo Y. Extracellularly activatable nanocarriers for drug delivery to tumors. Expert Opin Drug Deliv, 2014;11:1601–18.
   PubMed Web of Science ®Google Scholar
• Acharya SR, Reddy PRV. Brain targeted delivery of paclitaxel using endogenous ligand. Asian J Pharm Sci, 2016;11:427–38.
   Web of Science ®Google Scholar
• Apte MV, Wilson JS, Lugea A, Pandol SJ. A starring role for stellate cells in the pancreatic cancer microenvironment. Gastroenterology, 2013;144:1210–19.
   PubMed Web of Science ®Google Scholar
• Bertini I, Calderone V, Fragai M, Luchinat C, Maletta M, Yeo KJ. Snapshots of the reaction mechanism of matrix metalloproteinases. Angew Chem (Int Eng), 2006;45:7952–5.
   PubMed Web of Science ®Google Scholar
• Callmann CE, Barback CV, Thompson MP, Hall DJ, Mattrey RF, Gianneschi NC. Therapeutic enzyme-responsive nanoparticles for targeted delivery and accumulation in tumors. Adv Mater Weinheim, 2015;27:4611–15.
   PubMed Web of Science ®Google Scholar
• Cathcart J, Pulkoski-Gross A, Cao J. Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas. Genes Dis, 2015;2:26–34.
   PubMed Web of Science ®Google Scholar
• Cerqueira BB, Lasham A, Shelling AN, Al-Kassas R. Nanoparticle therapeutics: Technologies and methods for overcoming cancer. Eur J Pharm Biopharm, 2015;97:140–51.
   PubMed Web of Science ®Google Scholar
• Chen J, Cun X, Ruan S, Wang Y, Zhang Y, He Q, Gao H. Glioma cell-targeting doxorubicin delivery and redox-responsive release using angiopep-2 decorated carbonaceous nanodots. RSC Adv, 2015a;5:57045–9.
   Web of Science ®Google Scholar
• Chen WH, Luo GF, Lei Q, Jia HZ, Hong S, Wang QR, Zhuo RX, Zhang XZ. MMP-2 responsive polymeric micelles for cancer-targeted intracellular drug delivery. Chem Commun (Camb), 2015b;51:465–8.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Zuo T, Zeng H, Zhang S, He J. National cancer incidence and mortality in China, 2012. Chin J Cancer Res, 2016;28:1–11.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Huang F, Min X, Gao P, Zhang T, Li X, Liu B, Hong Y, Lou X, Xia F. Protease-responsive prodrug with aggregation-induced emission probe for controlled drug delivery and drug release tracking in living cells. Anal Chem, 2016;88:8913–19.
   PubMed Web of Science ®Google Scholar
• Cobo I, Li M, Sumerlin BS, Perrier S. Smart hybrid materials by conjugation of responsive polymers to biomacromolecules. Nat Mater, 2015;14:143–59.
   PubMed Web of Science ®Google Scholar
• Cun X, Chen J, Ruan S, Zhang L, Wan J, He Q, Gao H. A novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration. ACS Appl Mater Interfaces, 2015;7:27458–66.
   PubMed Web of Science ®Google Scholar
• Cun X, Ruan S, Chen J, Zhang L, Li J, He Q, Gao H. A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan. Acta Biomater, 2016;31:186–96.
   PubMed Web of Science ®Google Scholar
• Decuzzi P, Godin B, Tanaka T, Lee SY, Chiappini C, Liu X, Ferrari M. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release, 2010;141:320–7.
   PubMed Web of Science ®Google Scholar
• Devel L, Rogakos V, David A, Makaritis A, Beau F, Cuniasse P, Yiotakis A, Dive V. Development of selective inhibitors and substrate of matrix metalloproteinase-12. J Biol Chem, 2006;281:11152–60.
   PubMed Web of Science ®Google Scholar
• Du J, Lane LA, Nie S. Stimuli-responsive nanoparticles for targeting the tumor microenvironment. J Control Release, 2015;219:205–14.
   PubMed Web of Science ®Google Scholar
• Gao H. Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B, 2016;6:268–86.
   PubMed Web of Science ®Google Scholar
• Gao H, Jiang X. 2015. Brain delivery using nanotechnology. New York: John Wiley & Sons, Inc., pp. 521–34.
   Google Scholar
• Gao H, Yang Z, Zhang S, Cao S, Shen S, Pang Z, Jiang X. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci Rep, 2013;3:2534.
   PubMed Web of Science ®Google Scholar
• Gao H, Zhang Q, Yu Z, He Q. Cell-penetrating peptide-based intelligent liposomal systems for enhanced drug delivery. Curr Pharm Biotechnol, 2014a;15:210–19.
   PubMed Web of Science ®Google Scholar
• Gao H, Zhang S, Cao S, Yang Z, Pang Z, Jiang X. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery. Mol Pharm, 2014b;11:2755–63.
   PubMed Web of Science ®Google Scholar
• Gao W, Meng T, Shi N, Zhuang H, Yang Z, Qi X. Targeting and microenvironment-responsive lipid nanocarrier for the enhancement of tumor cell recognition and therapeutic efficiency. Adv Healthc Mater, 2015;4:748–59.
   PubMed Web of Science ®Google Scholar
• Garripelli VK, Kim JK, Son S, Kim WJ, Repka MA, Jo S. Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery. Acta Biomater, 2011;7:1984–92.
   PubMed Web of Science ®Google Scholar
• Ge Z, Liu S. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. Chem Soc Rev, 2013;42:7289–325.
   PubMed Web of Science ®Google Scholar
• Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J, 2011;278:16–27.
   PubMed Web of Science ®Google Scholar
• Grunwald B, Vandooren J, Locatelli E, Fiten P, Opdenakker G, Proost P, Krüger A, Lellouche JP, Israel LL, Shenkman L, Comes Franchini M. Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer. J Control Release, 2016;239:39–48.
   PubMed Web of Science ®Google Scholar
• Gu G, Xia H, Hu Q, Liu Z, Jiang M, Kang T, Miao D, Tu Y, Pang Z, Song Q, et al. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy. Biomaterials, 2013;34:196–208.
   PubMed Web of Science ®Google Scholar
• Gustafson JA, Price RA, Frandsen J, Henak CR, Cappello J, Ghandehari H. Synthesis and characterization of a matrix-metalloproteinase responsive silk-elastinlike protein polymer. Biomacromolecules, 2013;14:618–25.
   PubMed Web of Science ®Google Scholar
• Hu G, Chun X, Wang Y, He Q, Gao H. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment. Oncotarget, 2015a;6:41258–74.
   PubMed Web of Science ®Google Scholar
• Hu G, Zhang H, Zhang L, Ruan S, He Q, Gao H. Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment. Int J Pharm, 2015b;496:1057–68.
   PubMed Web of Science ®Google Scholar
• Huang Y, Jiang Y, Wang H, Wang J, Shin MC, Byun Y, He H, Liang Y, Yang VC. Curb challenges of the “Trojan Horse” approach: Smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. Adv Drug Deliv Rev, 2013;65:1299–315.
   PubMed Web of Science ®Google Scholar
• Jablonska-Trypuc A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem, 2016;31:177–83.
   PubMed Web of Science ®Google Scholar
• Ji T, Li S, Zhang Y, Lang J, Ding Y, Zhao X, Zhao R, Li Y, Shi J, Hao J, et al. An MMP-2 responsive liposome integrating antifibrosis and chemotherapeutic drugs for enhanced drug perfusion and efficacy in pancreatic cancer. ACS Appl Mater Interfaces, 2016;8:3438–45.
   PubMed Web of Science ®Google Scholar
• Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, Tsien RY. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci USA, 2004;101:17867–72.
   PubMed Web of Science ®Google Scholar
• Kalafatovic D, Nobis M, Javid N, Frederix PW, Anderson KI, Saunders BR, Ulijn RV. MMP-9 triggered micelle-to-fibre transitions for slow release of doxorubicin. Biomater Sci, 2015;3:246–9.
   PubMed Web of Science ®Google Scholar
• Kanasty R, Dorkin JR, Vegas A, Anderson D. Delivery materials for siRNA therapeutics. Nat Mater, 2013;12:967–77.
   PubMed Web of Science ®Google Scholar
• Ke W, Li J, Zhao K, Zha Z, Han Y, Wang Y, Yin W, Zhang P, Ge Z. Modular design and facile synthesis of enzyme-responsive peptide-linked block copolymers for efficient delivery of doxorubicin. Biomacromolecules, 2016;17:3268–76.
   PubMed Web of Science ®Google Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell, 2010;141:52–67.
   PubMed Web of Science ®Google Scholar
• Kibria G, Hatakeyama H, Ohga N, Hida K, Harashima H. The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells. Biomaterials, 2013;34:5617–27.
   PubMed Web of Science ®Google Scholar
• Kim HS, Yoo HS. MMPs-responsive release of DNA from electrospun nanofibrous matrix for local gene therapy: In vitro and in vivo evaluation. J Control Release, 2010;145:264–71.
   PubMed Web of Science ®Google Scholar
• King SE. Matrix metalloproteinases: New directions toward inhibition in the fight against cancers. Future Med Chem, 2016;8:297–309.
   PubMed Web of Science ®Google Scholar
• Kolate A, Baradia D, Patil S, Vhora I, Kore G, Misra A. PEG – a versatile conjugating ligand for drugs and drug delivery systems. J Control Release, 2014;192:67–81.
   PubMed Web of Science ®Google Scholar
• Kon S, Nakayama Y, Matsumoto N, Ito K, Kanayama M, Kimura C, Kouro H, Ashitomi D, Matsuda T, Uede T. A novel cryptic binding motif, LRSKSRSFQVSDEQY, in the C-terminal fragment of MMP-3/7-cleaved osteopontin as a novel ligand for α9β1 integrin is involved in the anti-type II collagen antibody-induced arthritis. PLoS One, 2014;9:e116210.
   PubMed Web of Science ®Google Scholar
• Kuang T, Liu Y, Gong T, Peng X, Hu X, Yu Z. Enzyme-responsive nanoparticles for anticancer drug delivery. Curr Nansci, 2016;12:38–46.
   Web of Science ®Google Scholar
• Kulkarni PS, Haldar MK, Nahire RR, Katti P, Ambre AH, Muhonen WW, Shabb JB, Padi SK, Singh RK, Borowicz PP, et al. Mmp-9 responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancer. Mol Pharm, 2014;11:2390–9.
   PubMed Web of Science ®Google Scholar
• Lamort AS, Gravier R, Laffitte A, Juliano L, Zani ML, Moreau T. New insights into the substrate specificity of macrophage elastase MMP-12. Biol Chem, 2016;397:469–84.
   PubMed Web of Science ®Google Scholar
• Li H, Miteva M, Kirkbride KC, Cheng MJ, Nelson CE, Simpson EM, Gupta MK, Duvall CL, Giorgio TD. Dual MMP7-proximity-activated and folate receptor-targeted nanoparticles for siRNA delivery. Biomacromolecules, 2015;16:192–201.
   PubMed Web of Science ®Google Scholar
• Li H, Yu SS, Miteva M, Nelson CE, Werfel T, Giorgio TD, Duvall CL. Matrix metalloproteinase responsive, proximity-activated polymeric nanoparticles for siRNA delivery. Adv Funct Mater, 2013;23:3040–52.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang B, Luo Z, Ding X, Li J, Dai L, Zhou J, Zhao X, Ye J, Cai K. Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo. Nanoscale, 2015c;7:3614–26.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ding X, Li J, Luo Z, Hu Y, Liu J, Dai L, Zhou J, Hou C, Cai K. Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo. Nanotechnology, 2015b;26:145102.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang D, Qiao ZY, Qi GB, Liang XJ, Chen XG, Wang H. A peptide-network weaved nanoplatform with tumor microenvironment responsiveness and deep tissue penetration capability for cancer therapy. Adv Mater, 2015a;27:5034–42.
   PubMed Web of Science ®Google Scholar
• Maeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev, 2013;65:71–9.
   PubMed Web of Science ®Google Scholar
• McCarthy DA, Nazem AA, McNeilan J, Shakerley NL, Clark RR, Idelchik MD, Yigit M, Melendez JA. Nanoenhanced matrix metalloproteinase-responsive delivery vehicles for disease resolution and imaging. Exp Biol Med (Maywood), 2016;241:2023–32.
   PubMed Web of Science ®Google Scholar
• Mei L, Zhang Q, Yang Y, He Q, Gao H. Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating. Int J Pharm, 2014;474:95–102.
   PubMed Web of Science ®Google Scholar
• Mi Y, Wolfram J, Mu C, Liu X, Blanco E, Shen H, Ferrari M. Enzyme-responsive multistage vector for drug delivery to tumor tissue. Pharmacol Res, 2016;113:92–9.
   PubMed Web of Science ®Google Scholar
• Mishra P, Nayak B, Dey RK. PEGylation in anti-cancer therapy: An overview. Asian J Pharm Sci, 2016;11:337–48.
   Web of Science ®Google Scholar
• Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies. Nat Rev Drug Discov, 2014;13:655–72.
   PubMed Web of Science ®Google Scholar
• Nazli C, Demirer GS, Yar Y, Acar HY, Kizilel S. Targeted delivery of doxorubicin into tumor cells via MMP-sensitive PEG hydrogel-coated magnetic iron oxide nanoparticles (MIONPs). Colloids Surf B Biointerfaces, 2014;122:674–83.
   PubMed Web of Science ®Google Scholar
• Olson ES, Jiang T, Aguilera TA, Nguyen QT, Ellies LG, Scadeng M, Tsien RY. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci USA, 2010;107:4311–16.
   PubMed Web of Science ®Google Scholar
• Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: Innovations for the post-trial era. Nat Rev Cancer, 2002;2:657–72.
   PubMed Web of Science ®Google Scholar
• Pan W, Arnone M, Kendall M, Grafstrom RH, Seitz SP, Wasserman ZR, Albright CF. Identification of peptide substrates for human MMP-11 (stromelysin-3) using phage display. J Biol Chem, 2003;278:27820–7.
   PubMed Web of Science ®Google Scholar
• Popovic Z, Liu W, Chauhan VP, Lee J, Wong C, Greytak AB, Insin N, Nocera DG, Fukumura D, Jain RK, et al. A nanoparticle size series for in vivo fluorescence imaging. Angew Chem Int Ed Engl, 2010;49:8649–52.
   PubMed Web of Science ®Google Scholar
• Price R, Poursaid A, Cappello J, Ghandehari H. In vivo evaluation of matrix metalloproteinase responsive silk-elastinlike protein polymers for cancer gene therapy. J Control Release, 2015;213:96–102.
   PubMed Web of Science ®Google Scholar
• Qiu WX, Liu LH, Li SY, Lei Q, Luo GF, Zhang XZ. ACPI conjugated gold nanorods as nanoplatform for dual image guided activatable photodynamic and photothermal combined therapy In Vivo. Small, 2017. [Epub ahead of print]. doi: 10.1002/smll.201603956
   Web of Science ®Google Scholar
• Ruan S, He Q, Gao H. Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma. Nanoscale, 2015d;7:9487–96.
   PubMed Web of Science ®Google Scholar
• Ruan S, Yuan M, Zhang L, Hu G, Chen J, Cun X, Zhang Q, Yang Y, He Q, Gao H. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles. Biomaterials, 2015a;37:425–35.
   PubMed Web of Science ®Google Scholar
• Ruan S, Cao X, Cun X, Hu G, Zhou Y, Zhang Y, Lu L, He Q, Gao H. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release. Biomaterials, 2015b;60:100–10.
   PubMed Web of Science ®Google Scholar
• Ruan S, Zhang L, Chen J, Cao T, Yang Y, Liu Y, He Q, Gao F, Gao H. Targeting delivery and deep penetration using multistage nanoparticles for triple-negative breast cancer. RSC Adv, 2015c;5:64303–17.
   Web of Science ®Google Scholar
• Ryu JH, Lee A, Na JH, Lee S, Ahn HJ, Park JW, Ahn CH, Kim BS, Kwon IC, Choi K. Optimization of matrix metalloproteinase fluorogenic probes for osteoarthritis imaging. Amino Acids, 2011;41:1113–22.
   PubMed Web of Science ®Google Scholar
• Shao K, Singha S, Clemente-Casares X, Tsai S, Yang Y, Santamaria P. Nanoparticle-based immunotherapy for cancer. ACS Nano, 2015;9:16–30.
   PubMed Web of Science ®Google Scholar
• Tang L, Yang X, Yin Q, Cai K, Wang H, Chaudhury I, Yao C, Zhou Q, Kwon M, Hartman JA, et al. Investigating the optimal size of anticancer nanomedicine. Proc Natl Acad Sci USA, 2014;111:15344–9.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov, 2014;13:813–27.
   PubMed Web of Science ®Google Scholar
• Turk BE, Huang LL, Piro ET, Cantley LC. Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat Biotechnol, 2001;19:661–7.
   PubMed Web of Science ®Google Scholar
• van der Meel R, Vehmeijer LJ, Kok RJ, Storm G, van Gaal EV. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status. Adv Drug Deliv Rev, 2013;65:1284–98.
   PubMed Web of Science ®Google Scholar
• van Duijnhoven SM, Robillard MS, Nicolay K, Grull H. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation. J Nucl Med, 2011;52:279–86.
   PubMed Web of Science ®Google Scholar
• Van Hove AH, Beltejar MJ, Benoit DS. Development and in vitro assessment of enzymatically-responsive poly(ethylene glycol) hydrogels for the delivery of therapeutic peptides. Biomaterials, 2014;35:9719–30.
   PubMed Web of Science ®Google Scholar
• van Rijt SH, Bolukbas DA, Argyo C, Datz S, Lindner M, Eickelberg O, Königshoff M, Bein T, Meiners S. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors. ACS Nano, 2015;9:2377–89.
   PubMed Web of Science ®Google Scholar
• Wan Y, Han J, Fan G, Zhang Z, Gong T, Sun X. Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity. Biomaterials, 2013;34:3020–30.
   PubMed Web of Science ®Google Scholar
• Wang B, Galliford CV, Low PS. Guiding principles in the design of ligand-targeted nanomedicines. Nanomedicine (Lond), 2014;9:313–30.
   PubMed Web of Science ®Google Scholar
• Wang HX, Yang XZ, Sun CY, Mao CQ, Zhu YH, Wang J. Matrix metalloproteinase 2-responsive micelle for siRNA delivery. Biomaterials, 2014;35:7622–34.
   PubMed Web of Science ®Google Scholar
• Wong C, Stylianopoulos T, Cui J, Martin J, Chauhan VP, Jiang W, Popovic Z, Jain RK, Bawendi MG, Fukumura D. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci USA, 2011;108:2426–31.
   PubMed Web of Science ®Google Scholar
• Xiao W, Zeng X, Lin H, Han K, Jia HZ, Zhang XZ. Dual stimuli-responsive multi-drug delivery system for the individually controlled release of anti-cancer drugs. Chem Commun (Camb), 2015;51:1475–8.
   PubMed Web of Science ®Google Scholar
• Xu Q, Liu Y, Su R, Cai L, Li B, Zhang Y, Zhang L, Wang Y, Wang Y, Li N, et al. Highly fluorescent Zn-doped carbon dots as Fenton reaction-based bio-sensors: An integrative experimental-theoretical consideration. Nanoscale, 2016;8:17919–27.
   PubMed Web of Science ®Google Scholar
• You X, Kang Y, Hollett G, Chen X, Zhao W, Gu Z, Wu J. Polymeric nanoparticles for colon cancer therapy: Overview and perspectives. J Mater Chem B, 2016;4:7779–92.
   PubMed Web of Science ®Google Scholar
• Yu C, Qian L, Ge J, Fu J, Yuan P, Yao SC, Yao SQ. Cell-penetrating poly(disulfide) assisted intracellular delivery of mesoporous silica nanoparticles for inhibition of miR-21 function and detection of subsequent therapeutic effects. Angew Chem Int Ed Engl, 2016;55:9272–6.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang X, Zhong W, Ren X, Sha X, Fang X. Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation. Int J Nanomedicine, 2016;11:1643–61.
   PubMed Web of Science ®Google Scholar
• Zhu L, Kate P, Torchilin VP. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. ACS Nano, 2012;6:3481–8.
   PubMed Web of Science ®Google Scholar
• Zhu L, Perche F, Wang T, Torchilin VP. Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs. Biomaterials, 2014;35:4213–22.
   PubMed Web of Science ®Google Scholar